CardioSignal

cardiosignal.com

Cardiosignal is a health technology company developing groundbreaking solutions for early detection of heart diseases. We are based in Turku, Finland, and Palo Alto, CA, United States. The Cardiosignal mobile application is a CE-marked Class IIA medical device for the detection of atrial fibrillation, available in over 10 countries. The technology we are developing enables a digital cardiac biomarker for other major heart diseases as well. Cardiosignal is a brand and a product by Precordior. Originally an academic spinoff, the company’s patented motion sensor technology is built on a decade of research and algorithm development. Our purpose is to support healthcare in battling the #1 killer of people in the world. With heart disease numbers only rising, we are facing a health and economic problem described as an epidemic by researchers and physicians around the world. Early identification and treatment of heart disease, such as atrial fibrillation, would help prevent strokes.